SCHEMBL4689979

SCHEMBL4689979

CC(C)(C#N)CC(=O)Cc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 2/20 0.44
CES2 O00748 1/20 0.44
AKR1B1 P15121 1/20 0.44
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
ALDH1A1 P00352 2/20 0.41
CYP2C19 P33261 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
VNN1 O95497 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
CTSS P25774 2/20 0.39
CTSK P43235 1/20 0.39
TSHR P16473 1/20 0.39
CTSL P07711 2/20 0.38
CTSB P07858 1/20 0.38
FNTA P49354 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10906216 0.80 CES1 (0.52) CES1CES2AKR1B1TDP1L3MBTL1
SCHEMBL10433055 0.74 HMGCR (0.32) CYP2C19TSHRHIF1A
Methyl Alcohol SCHEMBL11054071 0.72 CES1 (0.64) CES1CES2AKR1B1TDP1L3MBTL1
SCHEMBL6520274 0.72 CES1 (0.40) CES1CES2AKR1B1TDP1L3MBTL1
SCHEMBL77563 0.72 CES1 (0.70) CES1CES2AKR1B1TDP1L3MBTL1
SCHEMBL11378361 0.72 CES1 (0.52) CES1CES2AKR1B1TDP1L3MBTL1
SCHEMBL1033376 0.72 CES1 (0.59) CES1CES2AKR1B1TDP1L3MBTL1
SCHEMBL1529438 0.72 MCL1 (0.55) CES1CES2AKR1B1TDP1L3MBTL1
SCHEMBL5784144 0.71 SLC6A2 (0.52) ALDH1A1CYP2C19CYP3A4CYP2C9HIF1A
Benzene SCHEMBL27747096 0.71 CES1 (0.56) CES1CES2AKR1B1TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1419160-B1 METHOD FOR THE PRODUCTION OF 6-(4-CHLOROPHENYL)-2,2-DIMETHYL-7-PHENYL-2,3-DIHYDRO-1H-PYRROLIZIN-5-YLACETIC ACID MERCKLE GMBH (DE) 2008-12-10 EP disclosed
EP-1419160-B1 METHOD FOR THE PRODUCTION OF 6-(4-CHLOROPHENYL)-2,2-DIMETHYL-7-PHENYL-2,3-DIHYDRO-1H-PYRROLIZIN-5-YLACETIC ACID MERCKLE GMBH (DE) 2008-12-10 EP disclosed
EP-1419160-B1 METHOD FOR THE PRODUCTION OF 6-(4-CHLOROPHENYL)-2,2-DIMETHYL-7-PHENYL-2,3-DIHYDRO-1H-PYRROLIZIN-5-YLACETIC ACID MERCKLE GMBH (DE) 2008-12-10 EP disclosed
WO-2007108006-A1 PROCESS FOR THE PREPARATION OF 6-(4-CHLOROPHENYL)-2,2-DIMETHYL-7-PHENYL-2, 3-DIHYDRO-1H-PYRROLIZIN-5-YL ACETIC ACID AND ITS INTERMEDIATES UNICHEM LABORATORIES LIMITED (IN) 2007-09-27 WO disclosed
CN-1266152-C Method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid MERCKLE GMBH (DE) 2006-07-26 CN disclosed
CN-1266152-C Method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid MERCKLE GMBH (DE) 2006-07-26 CN disclosed
US-7078535-B2 Method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid MERCKLE GMBH (DE) 2006-07-18 US disclosed
US-7078535-B2 Method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid MERCKLE GMBH (DE) 2006-07-18 US disclosed
US-20040236117-A1 Method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid MERCKLE GMBH (DE) 2004-11-25 US disclosed
US-20040236117-A1 Method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid MERCKLE GMBH (DE) 2004-11-25 US disclosed
CN-1545516-A Process for producing 6- (4-chlorophenyl) -2, 2-dimethyl-7-phenyl-2, 3-dihydro-1H-pyrrolizin-5-ylacetic acid ��Ĭ���� 2004-11-10 CN disclosed
CN-1545516-A Process for producing 6- (4-chlorophenyl) -2, 2-dimethyl-7-phenyl-2, 3-dihydro-1H-pyrrolizin-5-ylacetic acid ��Ĭ���� 2004-11-10 CN disclosed
EP-1419160-A1 METHOD FOR THE PRODUCTION OF 6-(4-CHLOROPHENYL)-2,2-DIMETHYL-7-PHENYL-2,3-DIHYDRO-1H-PYRROLIZIN-5-YLACETIC ACID MERCKLE GMBH (DE) 2004-05-19 EP disclosed
EP-1419160-A1 METHOD FOR THE PRODUCTION OF 6-(4-CHLOROPHENYL)-2,2-DIMETHYL-7-PHENYL-2,3-DIHYDRO-1H-PYRROLIZIN-5-YLACETIC ACID MERCKLE GMBH (DE) 2004-05-19 EP disclosed
WO-2003018583-A1 METHOD FOR THE PRODUCTION OF 6-(4-CHLOROPHENYL)-2,2-DIMETHYL-7-PHENYL-2,3-DIHYDRO-1H-PYRROLIZIN-5-YLACETIC ACID MERCKLE GMBH (DE) 2003-03-06 WO disclosed
WO-2003018583-A1 METHOD FOR THE PRODUCTION OF 6-(4-CHLOROPHENYL)-2,2-DIMETHYL-7-PHENYL-2,3-DIHYDRO-1H-PYRROLIZIN-5-YLACETIC ACID MERCKLE GMBH (DE) 2003-03-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040236117-A1 Method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid KMO, HPD, PDK4 CES1 2611/4885CES2 2987/4885AKR1B1 143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.